editor

Washington Post: New Embryonic Stem Cell Experiment

Government regulators have given the go-ahead to a second study that will for the first time carefully test a treatment created using human embryonic stem cells in people, according to the company sponsoring the experiment.

USA Today: Second human embryonic stem cell clinical trial to start

Federal officials have cleared a second clinical trial of a human embryonic stem-cell treatment, a company announced Monday, for a progressive blindness syndrome affecting young people.

Associated Press: Feds OK 2nd Human Study of Embryonic Stem Cells

NEW YORK (AP) – For only the second time, the U.S. government has approved a test in people of a treatment using embryonic stem cells – this time for a rare disease that causes serious vision loss.

New York Times: 2 Treatments for Retinas Make Gains

Advanced Cell Technology, of Marlborough, Mass., said it would test its stem cell therapy on 12 adults with severe vision loss caused by Stargardt’s, an inherited disease. The company has turned human embryonic stem cells into retinal pigment epithelial cells,...

Paradigm Shifter: An Interview with Robert Lanza

“An interview with the author of Biocentrism, a book that Nyogen Roshi (the last authorized disciple of Taizan Maezumi Roshi, the foremost Zen master of the twentieth century) describes as mirroring his experiences in the practice of zazen as closely...

Drs. Robert Lanza and Kwang-Soo Kim Win Prestigious NIH Director’s Award

Robert Lanza and Kwang-Soo Kim of Harvard University have won a National Institutes of Health (NIH) Director’s Opportunity Award for research in “Translating Basic Science Discoveries into New and Better Treatments” under the American Recovery & Reinvestment Act of 2009....

Dr. Robert Lanza Honored By BioWorld Magazine As Leader Who Could Shape Biotech Over Next 20 Years

Dr. Lanza Recognized as a “Stem Cell Pioneer”WORCESTER, MA – May 10, 2010 (BUSINESS WIRE)—Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC) announced today that the company’s Chief Scientific Officer, Robert Lanza, MD, has been recognized by BioWorld, a widely-read publication...

CBS News: The Trouble With Adult Stem Cells. Research Shows Why They Won’t Displace Embryonic Ones

BY ANDREW MOSEMAN When scientists first created induced pluripotent stem cells (iPS cells) three years ago, they were hailed as a game-changing advance for medicine: Scientists hoped the engineered cells could duplicate the talents of embryonic stem cells, which can...

NEWSWEEK: Still No Truce in the Stem-Cell Wars

by Sharon BegleyEmbryonic” and “senescent” aren’t supposed to go together any more than “good” and “grief” or other oxymorons, which is why biologist Robert Lanza was “devastated” when he saw what was happening with the human stem cells he and...

TIME: Researchers Hail Stem Cells Safe for Human Use

By Alice ParkStem-cell science is a fast-moving field. Just three years since a Japanese researcher first reprogrammed ordinary skin cells into stem cells without the use of embryos, scientists at a Massachusetts biotech company have repeated the feat, only this...

Is Death An Illusion? Evidence Suggests Death Isn’t the End

[mashshare] Robert Lanza on Psychology Today - Is Death An Illusion? Evidence Suggests Death Isn’t the EndEvidence suggests death isn’t the end. After the death of his old friend, Albert Einstein said “Now Besso has departed from this strange world...

Robert Lanza in Yankee Magazine

Scientist in a TreehouseMany years ago, as a young boy, I persuaded myself to make an immense journey.

Astellas Executive Interview Series – Dr. Bob Lanza

Since he was a child, Dr. Bob Lanza has been fascinated by science and human health. He spent his early years attempting to better understand how the cells in the body interact and how they had a special capacity to...

Lanza receives the Marquis Who’s Who Lifetime Achievement Award

Lanza featured on the Canadian Broadcast Corporation (CBC’s) Ideas, one of the oldest and most respected radio programs in the world

Lanza’s new paper published in leading physics journal

Observers determine the structure of spacetime itselfThe paper—published in the Journal of Cosmology and Astroparticle Physics (one of the world’s leading journals in cosmology & astrophysics, covering the latest developments and breakthroughs including Stephen Hawking’s groundbreaking work on the evolution...

Lanza and Podolskiy’s paper is the cover story of Annalen der Physik, which published Einstein’s theories of special and general relativity

On Decoherence in Quantum Gravity In his papers on relativity, Einstein showed that time was relative to the observer. This new paper takes this one step further, arguing that the observer creates it. The paper shows that the intrinsic properties...

Lanza’s new book released

THE GRAND BIOCENTRIC DESIGN: How Life Creates RealityWhy are we here? Where did it all come from―the laws of nature, the stars, the universe. Humans have been asking these questions forever, but science hasn’t succeeded in providing many answers—until now....

Lanza Featured in OMNI MAGAZINE’s Collector’s Edition

Omni Magazine is back. Featured story: Building Doctor Who’s Time MachineWhat if you could travel through time just like you navigate space? The journey starts here

Lanza named head of Astellas global regenerative medicine

“Robert Lanza, one of the most prominent scientists in the field of stem cell biology, on Monday said he will lead global regenerative medicine research at Astellas Pharma Inc., the Japanese drug maker that acquired his Massachusetts company this month....

Lanza gives opening address at the Massachusetts State Science & Engineering Fair

Lanza delivered the opening address to the judges and students at the Official Opening of 2015 MSSEF held at the Massachusetts Institute of Technology. MSSEF was founded by the prestigious American Academy of Arts & Sciences and

Lanza’s work voted the top science story of the year

Winner of Discover Magazine’s ‘People’s Choice’ Award Stem cell breakthrough by Lanza and colleagues was voted the year's top story, beating the Ebola outbreak, climate change crisis, entangled photons, cosmic inflation, as well as the year's other science stories ranging...

First report of the long-term safety/efficacy of pluripotent stem cells in humans with any disease

“For a nice two decades scientists have dreamt about using human embryonic stem cells to treat diseases … that day has finally come…scientists have used human embryonic stem cells to successfully treat patients suffering from severe vision loss”

In a cloning first, Lanza and colleagues create stem cells from adults

“Advancement Could Lead to Treatment for Alzheimer’s, Heart Disease” Wall Street Journal [Read More] “After years of failed attempts, researchers have finally generated stem cells from adults using the same cloning technique that produced Dolly the sheep in 1996. The...